Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion.

ABSTRACT:

Background

Transarterial chemo-embolisation (TACE) is recommended for patients with BCLC intermediate stage hepatocellular carcinoma (stage B), particularly in patients with good underlying liver function and minimal symptoms. The hepatoma arterial embolisation prognostic (HAP) score combines measures of liver function and tumour-related factors to offer a simple prognostic scoring system. The Albumin-Bilirubin (ALBI) grade permits assessment of the impact of liver function on survival. We aimed to investigate these two models and vascular invasion (VI).

Methods

In an international cohort of 3030 patients undergoing TACE, we examined the impact of liver function as assessed by the ALBI score, the HAP score and VI on survival.

Results

Classification according to ALBI g

SUBMITTER: Waked I 

PROVIDER: S-EPMC5318968 | biostudies-literature | 2017 Feb

REPOSITORIES: biostudies-literature